Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    "Retinal cone dystrophy 4"
Show Display Options
Rank Status Study
1 Completed A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex
Condition: HIV Infections
Intervention: Drug: CD4 Antigens
2 Completed An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive
Condition: HIV Infections
Intervention: Drug: CD4 Antigens
3 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex
Condition: HIV Infections
Intervention: Drug: CD4 Antigens
4 Completed A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura
Conditions: Immune Thrombocytopenic Purpura ( ITP );   HIV Infections
Intervention: Drug: CD4-IgG
5 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection
Condition: HIV Infections
Intervention: Drug: CD4 Antigens
6 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: CD4-IgG
7 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
Condition: HIV Infections
Intervention: Drug: CD4-IgG
8 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: CD4-IgG
9 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
Condition: HIV Infections
Interventions: Drug: CD4-IgG;   Drug: Zidovudine

Indicates status has not been verified in more than two years